Cargando…
Lymphocyte Sensitization in Advanced Malignant Disease: A Study of Serum Lymphocyte Depressive Factor
Patients with advanced malignant disease show an apparent lesser degree of lymphocyte sensitization to cancer antigen when tested under standard conditions than do early cases. In the serum of cancer patients there is a lymphocyte response depressing factor whose titre rises as the neoplasm becomes...
Autores principales: | Field, E. J., Caspary, E. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1972
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008474/ https://www.ncbi.nlm.nih.gov/pubmed/5047140 |
Ejemplares similares
-
Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis
por: Stadler, Michael, et al.
Publicado: (2022) -
Depression in association with neutrophil-to-lymphocyte, platelet-to-lymphocyte, and advanced lung cancer inflammation index biomarkers predicting lung cancer survival
por: Andersen, Barbara L., et al.
Publicado: (2023) -
The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies – A Narrative Review
por: Stefaniuk, Paulina, et al.
Publicado: (2020) -
FEEDBACK INHIBITION OF SPECIFICALLY SENSITIZED LYMPHOCYTES
por: Mackaness, G. B., et al.
Publicado: (1974) -
A Common Tumour Specific Antigen: I. Restriction in vivo to Malignant Neoplastic Tissue
por: Dickinson, J. P., et al.
Publicado: (1973)